{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:30:46Z","timestamp":1786595446907,"version":"build-2736575974"},"reference-count":37,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autoinflammatory diseases (AIDs) are a heterogeneous group of innate immune-driven disorders whose prevalence is rising globally, yet the lack of disease-specific biomarkers continues to hamper accurate disease activity assessment, phenotype stratification, and risk evaluation. C-reactive protein (CRP) is one of the most widely used markers of systemic inflammation, yet its disease-specific expression, clinical correlations, network connectivity, and cellular origin across both adult and pediatric AIDs have not been systematically examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We established a single-center retrospective cohort including 11 adult and pediatric AIDs and age matched healthy controls. Baseline CRP measurements were obtained before anti-inflammatory or immunosuppressive therapy. We performed multivariate regression and subgroup analyses to examine the associations of CRP and its composite indices, the CRP to lymphocyte ratio (CLR) and CRP to albumin ratio (CAR), with different AIDs. We integrated a public serum proteomic dataset to construct CRP centered protein interaction networks in macrophage activation syndrome. We also analyzed single cell CITE seq and spatial transcriptomic data from healthy human liver to determine the cellular origin of CRP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serum CRP levels showed a disease specific distribution across AIDs, with the highest levels in hyperinflammatory conditions such as AOSD and MAS. CRP correlated with fever, rash, and arthralgia in AOSD, but showed no association with mucosal or articular phenotypes in other diseases. Both CLR and CAR showed stronger associations with disease risk than CRP alone in regression models. Proteomic network analysis positioned CRP as a prominently connected node in the MAS inflammatory interactome. Single cell and spatial transcriptomic data confirmed hepatocytes as the exclusive source of CRP transcripts in healthy human liver.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These findings indicate a positive association of CRP and its composite indices with AIDs, suggesting their potential as disease-specific biomarkers. Yet, given the single-center retrospective design and lack of external validation, further multi-center prospective studies are required before clinical implementation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1874052","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:24:05Z","timestamp":1786595045000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Disease-specific biomarker value of C-reactive protein and its composite indices in autoinflammatory diseases: an integrated study of multi-modal omics and population cohorts"],"prefix":"10.3389","volume":"17","author":[{"given":"Qianyue","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuning","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuting","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Central Hospital of Shaoyang, Shaoyang","place":["Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Nanjing, China"]},{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University","place":["Nanjing, China"]},{"name":"Department of Rheumatology and Immunology, Nanjing Drum Tower Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2023-1209","article-title":"Autoinflammatory diseases: a review","volume":"51","author":"An","year":"2024","journal-title":"J Rheumatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s12016-023-08971-3","article-title":"Autoinflammatory keratinization diseases-the concept, pathophysiology, and clinical implications","volume":"65","author":"Blicharz","year":"2023","journal-title":"Clin Rev Allergy Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17030","article-title":"Cutaneous vasculitis in autoinflammatory diseases","volume":"51","author":"Chen","year":"2024","journal-title":"J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-023-09375-3","article-title":"Autoinflammatory diseases and the kidney","volume":"71","author":"Hegazy","year":"2023","journal-title":"Immunol Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000953","article-title":"Update on autoinflammatory diseases","volume":"35","author":"Ashari","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216040","article-title":"Mesenchymal stem cells in the pathogenesis and therapy of autoimmune and autoinflammatory diseases","volume":"24","author":"Zaripova","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103520","article-title":"Disease phenotypes in adult patients with suspected undifferentiated autoinflammatory diseases and PFAPA syndrome: clinical and therapeutic implications","volume":"23","author":"G\u00f3mez-Caverzaschi","year":"2024","journal-title":"Autoimmun Rev"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18999\/nagjms.86.1.1","article-title":"Diseases categorized as autoinflammatory keratinization diseases (AiKDs), and their pathologies and treatments","volume":"86","author":"Akiyama","year":"2024","journal-title":"Nagoya J Med Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.yapd.2024.02.001","article-title":"Overview of systemic autoinflammatory diseases","volume":"71","author":"Nazzar Romero","year":"2024","journal-title":"Adv Pediatr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2025.105903","article-title":"Dysregulation of inflammasomes in autoinflammatory diseases","volume":"92","author":"Hou","year":"2025","journal-title":"Joint Bone Spine"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.revmed.2024.08.003","article-title":"Autoinflammatory diseases associated with IL-18","volume":"46","author":"Mertz","year":"2025","journal-title":"Rev Med Interne"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-023-05491-3","article-title":"SAPHO syndrome: current clinical, diagnostic and treatment approaches","volume":"44","author":"Demirci Yildirim","year":"2024","journal-title":"Rheumatol Int"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1016\/j.jid.2023.12.007","article-title":"A20 haploinsufficiency: a systematic review of 177 cases","volume":"144","author":"Elhani","year":"2024","journal-title":"J Invest Dermatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-genet-030123-084224","article-title":"How to build a fire: the genetics of autoinflammatory diseases","volume":"57","author":"Zhang","year":"2023","journal-title":"Annu Rev Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12969-022-00757-9","article-title":"The relation between C-reactive protein and serum amyloid A in patients with autoinflammatory diseases","volume":"20","author":"Legger","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-225640","article-title":"Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX","volume":"83","author":"Hadjadj","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/S2665-9913(25)00034-7","article-title":"Treatment outcomes in patients with VEXAS syndrome: a retrospective cohort study","volume":"7","author":"Al-Hakim","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae530","article-title":"Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry","volume":"64","author":"Kirino","year":"2025","journal-title":"Rheumatol (Oxford)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2023-003419","article-title":"Derivation and validation of four patient clusters in Still\u2019s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry","volume":"9","author":"Ruscitti","year":"2023","journal-title":"RMD Open"},{"key":"B20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s13023-025-03878-y","article-title":"Clinical features and novel pathogenic variants of patients with Behcet\u2019s disease like trisomy 8","volume":"20","author":"Ding","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2024.105772","article-title":"Systemic auto-inflammatory manifestations in patients with spondyloarthritis","volume":"91","author":"Gaggiano","year":"2024","journal-title":"Joint Bone Spine"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-025-07617-3","article-title":"A cross-sectional survey on VEXAS syndrome: insights from a global expert panel","volume":"44","author":"Ali","year":"2025","journal-title":"Clin Rheumatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-024-02170-y","article-title":"Old and new biomarkers in idiopathic recurrent acute pericarditis (IRAP): prognosis and outcomes","volume":"27","author":"Mascolo","year":"2025","journal-title":"Curr Cardiol Rep"},{"key":"B24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10875-025-01932-9","article-title":"Diagnostic and monitoring strategies for VEXAS syndrome: evaluating Sanger sequencing, NGS, and the SWIM-Score","volume":"45","author":"von Bornemann Fl\u00f8e","year":"2025","journal-title":"J ClinImmunol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/s13023-022-02364-z","article-title":"Clinical and genetic spectrum of 14 cases of NLRP3-associated autoinflammatory disease (NLRP3-AID) in China and a review of the literature","volume":"17","author":"Zhou","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2020.102421","article-title":"Systemic autoinflammatory diseases","volume":"109","author":"Krainer","year":"2020","journal-title":"J Autoimmun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1542\/pir.2022-005635","article-title":"Autoinflammatory diseases\/periodic fevers","volume":"44","author":"Schutt","year":"2023","journal-title":"Pediatr Rev"},{"key":"B28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.coi.2018.09.014","article-title":"Updates on autoinflammatory diseases","volume":"55","author":"Martinez-Quiles","year":"2018","journal-title":"Curr Opin Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-315079","article-title":"How to use C-reactive protein","volume":"104","author":"Dyer","year":"2019","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-019-01269-1","article-title":"Regulation of C-reactive protein conformation in inflammation","volume":"68","author":"Yao","year":"2019","journal-title":"Inflammation Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1389710","article-title":"Heterogeneity of macrophage activation syndrome and treatment progression","volume":"15","author":"Dong","year":"2024","journal-title":"Front Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1425168","article-title":"C-reactive protein: structure, function, regulation, and role in clinical diseases","volume":"15","author":"Zhou","year":"2024","journal-title":"Front Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/psyg.70032","article-title":"C-reactive protein-mediated dementia","volume":"25","author":"Tang","year":"2025","journal-title":"Psychogeriatrics"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23158100","article-title":"C-reactive protein velocity (CRPv) as a new biomarker for the early detection of acute infection\/inflammation","volume":"23","author":"Levinson","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1515\/cclm-2023-0086","article-title":"Why C-reactive protein is one of the most requested tests in clinical laboratories","volume":"61","author":"Plebani","year":"2023","journal-title":"Clin Chem Lab Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1150103","article-title":"C-reactive protein - my perspective on its first half century, 1930-1982","volume":"14","author":"Kushner","year":"2023","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae1080","article-title":"Harmonizome 3.0: integrated knowledge about genes and proteins from diverse multi-omics resources","volume":"53","author":"Diamant","year":"2025","journal-title":"Nucleic Acids Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1874052\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:24:07Z","timestamp":1786595047000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1874052\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":37,"alternative-id":["10.3389\/fimmu.2026.1874052"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1874052","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"article-number":"1874052"}}